Expression of cell-surface antigens in acute promyelocytic leukaemia
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 16 (3) , 369-385
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemiaLeukemia, 2002
- Expression of CD117 and CD11b in Bone Marrow Can Differentiate Acute Promyelocytic Leukemia From Recovering Benign Myeloid ProliferationAmerican Journal of Clinical Pathology, 2002
- Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignanciesBlood Reviews, 2001
- Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML‐RARα isoforms: a study of the PETHEMA groupBritish Journal of Haematology, 2001
- Submicroscopic Insertion of RARα Gene into Chromosome 15 in Two Cases of Acute Promyelocytic LeukemiaCancer Genetics and Cytogenetics, 2000
- Multidrug resistance in haematological malignanciesJournal of Internal Medicine, 2000
- Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARα rearrangement in newly diagnosed AMLBritish Journal of Haematology, 1999
- Acute Promyelocytic Leukemia Toluidine Blue SubtypeLeukemia & Lymphoma, 1995
- Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c‐kitBritish Journal of Haematology, 1992
- Surface marker analysis in acute myeloid leukaemia and correlation with FAB classificationBritish Journal of Haematology, 1986